Immunological markers contributing to successful aging in Bulgarians.
In order to clarify immunogenetic markers contributing to successful aging, HLA and cytokine gene profiles were analyzed in healthy elderly Bulgarians. Family segregation analysis was performed to define combined effect of haplotypes and immunophenotype profiles. The results of this study did not reveal any statistically significant allele and haplotype frequency differences between elderly and control group. In families with two generations longevity members we did not observed HLA alleles and haplotypes associated with autoimmunity. IL-10 genotype -1082G/A, -819 C/C, -592 C/C, related to the intermediate production, was positively associated, while genotype -1082A/A, -819 C/T, -592 C/A, related to the low level of production, was negatively associated with longevity in Bulgarians. This effect was modulated by IL-6 and IFNgamma genotypes associated with the low level of these pro-inflammatory cytokines. Immunophenotypic studies indicated lower relative and absolute numbers of CD3+8+, CD8+28+ and CD8+57+ cells in elderly people. Analysis in families showed that although most pronounced in the elderly group, lower numbers of CD8+ T cells were also found in middle aged and young members of the families compared to the age matched controls. A progressive CD8+28+ cell subsets decline was seen with aging. In addition, we did not observed the 'immune risk phenotype' which is a marker of an increased inflammatory activity. Based on the results of this study, it seems reasonable to suggest that a combination of specific immunogenetic and immunophenotype profiles could contribute to the successful aging and to maintaining healthy status in elderly.
Naumova
Elissaveta
E
Central Laboratory of Clinical Immunology, University Hospital Alexandrovska, 1 Georgy Sofiisky Str, 1431 Sofia, Bulgaria. immun@medun.acad.bg
Mihaylova
Anastasia
A
Ivanova
Milena
M
Michailova
Snejina
S
Penkova
Kalina
K
Baltadjieva
Daniela
D
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000208:ethnology / Q000235:genetics / Q000276:immunology*; D002031:Bulgaria; D016207:Cytokines / Q000235:genetics; D005260:Female; D005787:Gene Frequency / Q000276:immunology; D005805:Genes, MHC Class I / Q000276:immunology; D005802:Genes, MHC Class II / Q000276:immunology; D006239:Haplotypes; D006801:Humans; D016130:Immunophenotyping; D008136:Longevity / Q000235:genetics / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D010375:Pedigree; D011110:Polymorphism, Genetic; D016176:T-Lymphocyte Subsets / Q000276:immunology
D016207:Cytokines